A DISEASE-ASSOCIATED GERMLINE DELETION MAPS THE TYPE-2 NEUROFIBROMATOSIS (NF2) GENE BETWEEN THE EWING SARCOMA REGION AND THE LEUKEMIA INHIBITORY FACTOR LOCUS

被引:44
作者
WATSON, CJ
GAUNT, L
EVANS, G
PATEL, K
HARRIS, R
STRACHAN, T
机构
[1] UNIV NEWCASTLE UPON TYNE,DIV HUMAN GENET,MOLEC GENET UNIT,RIDLEY BLDG,CLAREMONT PL,NEWCASTLE TYNE NE1 7RU,TYNE & WEAR,ENGLAND
[2] NATL INST MED RES,LONDON NW7 1AA,ENGLAND
[3] UNIV MANCHESTER,ST MARYS HOSP,DEPT MED GENET,MANCHESTER M13 0JH,LANCS,ENGLAND
关键词
D O I
10.1093/hmg/2.6.701
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
RFLP typing of members of a neurofibromatosis type 2 (NF2) family suggested that affected individuals were hemizygous at the neurofilament heavy chain (NEFH) locus, possibly as a result of a disease-associated deletion. Conventional karyotyping revealed no evidence for a deletion and all or a majority of the affected family members were heterozygous for closely linked markers which mapped proximal to the NEFH locus (D22S1 and D22S56) and for the distal marker D22S32. FISH analysis confirmed a disease-associated germinal deletion on 22q which encompassed the NEFH locus, which is known to be very closely linked to NF2, but did not extend as far as the proximal Ewing sarcoma region or the distal leukaemia factor (LIF) locus. PFGE analysis with a LIF cosmid subclone identified patient-specific NotI and MluI fragments and suggested that the deletion is about 700 kb in length. Although this large deletion could be expected to eliminate a considerable fraction, and possibly all of the NF2 gene, the resulting phenotype is the mild, so-called Gardner subtype of NF2. The deletion should provide a useful mapping resource for characterising the chromosomal region containing the NF2 locus.
引用
收藏
页码:701 / 704
页数:4
相关论文
共 21 条
[1]   CONSTITUTIONAL TRANSLOCATION T(4,22) (Q12,Q12.2) ASSOCIATED WITH NEUROFIBROMATOSIS TYPE-2 [J].
ARAI, E ;
IKEUCHI, T ;
KARASAWA, S ;
TAMURA, A ;
YAMAMOTO, K ;
KIDA, M ;
ICHIMURA, K ;
YUASA, Y ;
TONOMURA, A .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1992, 44 (02) :163-167
[2]   RESTRICTION SITES CONTAINING CPG SHOW A HIGHER FREQUENCY OF POLYMORPHISM IN HUMAN DNA [J].
BARKER, D ;
SCHAFER, M ;
WHITE, R .
CELL, 1984, 36 (01) :131-138
[3]   ISOLATION AND REGIONAL LOCALIZATION OF 35 UNIQUE ANONYMOUS DNA MARKERS FOR HUMAN-CHROMOSOME 22 [J].
BUDARF, ML ;
MCDERMID, HE ;
SELLINGER, B ;
EMANUEL, BS .
GENOMICS, 1991, 10 (04) :996-1002
[4]   A MAJOR SEGMENT OF THE NEUROFIBROMATOSIS TYPE-1 GENE - CDNA SEQUENCE, GENOMIC STRUCTURE, AND POINT MUTATIONS [J].
CAWTHON, RM ;
WEISS, R ;
XU, GF ;
VISKOCHIL, D ;
CULVER, M ;
STEVENS, J ;
ROBERTSON, M ;
DUNN, D ;
GESTELAND, R ;
OCONNELL, P ;
WHITE, R .
CELL, 1990, 62 (01) :193-201
[5]   GENE FUSION WITH AN ETS DNA-BINDING DOMAIN CAUSED BY CHROMOSOME-TRANSLOCATION IN HUMAN TUMORS [J].
DELATTRE, O ;
ZUCMAN, J ;
PLOUGASTEL, B ;
DESMAZE, C ;
MELOT, T ;
PETER, M ;
KOVAR, H ;
JOUBERT, I ;
DEJONG, P ;
ROULEAU, G ;
AURIAS, A ;
THOMAS, G .
NATURE, 1992, 359 (6391) :162-165
[6]  
DEPREZ RHL, 1991, AM J HUM GENET, V48, P783
[7]   A GENETIC-STUDY OF TYPE-2 NEUROFIBROMATOSIS IN THE UNITED-KINGDOM .1. PREVALENCE, MUTATION-RATE, FITNESS, AND CONFIRMATION OF MATERNAL TRANSMISSION EFFECT ON SEVERITY [J].
EVANS, DGR ;
HUSON, SM ;
DONNAI, D ;
NEARY, W ;
BLAIR, V ;
TEARE, D ;
NEWTON, V ;
STRACHAN, T ;
RAMSDEN, R ;
HARRIS, R .
JOURNAL OF MEDICAL GENETICS, 1992, 29 (12) :841-846
[8]  
EVANS DGR, 1992, Q J MED, V84, P603
[9]   ISOLATION AND MAPPING OF A POLYMORPHIC DNA-SEQUENCE (PEFZ31) ON CHROMOSOME-22 [D22S32] [J].
KRAPCHO, K ;
NAKAMURA, Y ;
FUJIMOTO, E ;
ELDRIDGE, R ;
LEPPERT, M ;
OCONNELL, P ;
LATHROP, GM ;
LALOUEL, JM ;
WHITE, R .
NUCLEIC ACIDS RESEARCH, 1988, 16 (11) :5221-5221
[10]   HINCII RFLP IN THE HUMAN-GENE FOR THE HEAVY NEUROFILAMENT SUBUNIT (NF-H) [J].
LACOSTEROYAL, G ;
MATHIEU, M ;
GAUVREAU, D .
NUCLEIC ACIDS RESEARCH, 1989, 17 (15) :6434-6434